Folate and Linzess drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Folate (folic acid) and Linzess (linaclotide). Common drug interactions include somnolence among females and hypersomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Folate and Linzess. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Folate?

Folate has active ingredients of folic acid. It is often used in rheumatoid arthritis. eHealthMe is studying from 6,546 Folate users. Check the latest studies of Folate.

What is Linzess?

Linzess has active ingredients of linaclotide. It is often used in constipation. eHealthMe is studying from 24,086 Linzess users. Check the latest studies of Linzess.



On Jul, 16, 2026

38 people who take Folate and Linzess together, and have interactions are studied.

Folate and Linzess drug interactions.

What are the common drug interactions of Folate and Linzess, by gender? *:

female:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Subcutaneous abscess
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Therapeutic response unexpected
  5. Type 2 diabetes mellitus
  6. Vomiting
  7. Weight fluctuation
  8. Gait disturbance
  9. Pain
  10. Hyperhidrosis (abnormally increased sweating)

male:

  1. Hypersomnia (excessive daytime sleepiness (eds))
  2. Pain
  3. Injection site erosion
  4. Injection site extravasation (flow of (blood or lymph) from injection site)
  5. Injection site induration
  6. Injection site pain
  7. Pneumonia
  8. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  9. Respiratory disorder (respiratory disease)
  10. Wound

What are the common drug interactions of Folate and Linzess, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  2. Injection site bruising
  3. Injection site erosion
  4. Injection site extravasation (flow of (blood or lymph) from injection site)
  5. Injection site induration
  6. Injection site pain
  7. Hyperhidrosis (abnormally increased sweating)
  8. Sleep disorder
  9. Somnolence (a state of near-sleep, a strong desire for sleep)

30-39:

n/a

40-49:

  1. Breast cancer
  2. Cardiac failure congestive
  3. Cataract (clouding of the lens inside the eye)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Facial paralysis (loss of function of face muscle)
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  8. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  9. Neuropathy peripheral (surface nerve damage)
  10. Pleural effusion (water on the lungs)

50-59:

  1. Gait disturbance
  2. Pain
  3. Hyperhidrosis (abnormally increased sweating)
  4. Insomnia (sleeplessness)
  5. Tremor (trembling or shaking movements in one or more parts of your body)
  6. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Back pain
  10. Depression

60+:

  1. Chronic kidney disease
  2. Hypersomnia (excessive daytime sleepiness (eds))
  3. Blood potassium decreased
  4. Blood testosterone decreased
  5. Cardiac failure congestive
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Diarrhoea
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Fatigue (feeling of tiredness)
  10. Headache (pain in head)

What are the existing conditions these people have? *

  1. Irritable Bowel Syndrome: 9 people, 23.68%
  2. Pain: 8 people, 21.05%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 21.05%
  4. High Blood Cholesterol: 7 people, 18.42%
  5. Hypersensitivity: 6 people, 15.79%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 15.79%
  7. Nausea (feeling of having an urge to vomit): 6 people, 15.79%
  8. Headache (pain in head): 6 people, 15.79%
  9. Cardiac Disorder: 5 people, 13.16%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 13.16%

* Approximation only. Some reports may have incomplete information.

Do you take Folate and Linzess?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Folate and Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Folate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Folate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Linzess and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on folic acid and linaclotide (the active ingredients of Folate and Linzess, respectively), and Folate and Linzess (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: